联系客服

002437 深市 誉衡药业


首页 公告 誉衡药业:2023年度财务决算报告

誉衡药业:2023年度财务决算报告

公告日期:2024-04-20

誉衡药业:2023年度财务决算报告 PDF查看PDF原文

证券代码:002437        证券简称:誉衡药业        公告编号:2024-023
                哈尔滨誉衡药业股份有限公司

                  2023 年度财务决算报告

  本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。

  哈尔滨誉衡药业股份有限公司(以下简称“公司”)2023 年 12 月 31 日母公
司及合并的资产负债表、2023 年度母公司及合并的利润表、2023 年度母公司及合并的现金流量表、2023 年度母公司及合并的所有者权益变动表及相关报表附注已经上会会计师事务所(特殊普通合伙)审计,并出具了标准无保留意见的审计报告。

    一、2023 年度经营成果

  报告期内,公司主要会计数据和财务指标如下:

                        2023 年          2022 年        本年比上年增减        2021 年

 营业收入(元)    2,626,039,306.71  3,107,945,160.60          -15.51%  3,145,311,703.84

 归属于上市公司股    120,334,186.37  -291,328,832.92          141.31%    45,042,024.98
 东的净利润(元)
 归属于上市公司股

 东的扣除非经常性    53,377,327.33  -304,466,519.92          117.53%    -26,373,724.22
 损益的净利润(元)

 经营活动产生的现    274,175,284.57    261,615,607.78            4.80%    274,181,021.44
 金流量净额(元)

 基本每股收益(元            0.0547          -0.1325          141.28%            0.0205
 /股)

 稀释每股收益(元            0.0547          -0.1325          141.28%            0.0205
 /股)

 加权平均净资产收            7.26%          -16.55%            23.81%            2.41%
 益率

                      2023 年末        2022 年末      本年末比上年末增      2021 年末

                                                              减

 总资产(元)      3,152,450,105.19  4,074,185,955.01          -22.62%  4,695,143,655.89

 归属于上市公司股  1,661,773,347.48  1,631,237,579.41            1.87%  1,894,213,426.48
 东的净资产(元)

注:公司于 2024 年 4 月 18 日召开的第六届董事会第十三次会议、第六届监事会第十一次会议通过了《关
于会计政策变更的议案》。公司自 2023 年 1 月 1 日起将公司各下属子公司向合作客户支付的合作产品专利
/技术/商标使用费等,由利润表中的“销售费用”调整为“营业成本”列报。此项会计政策变更采用追溯调整法,对财务报表的营业成本及销售费用产生影响,对总资产、净资产、营业收入和净利润等均无影响。
    二、主营业务分析


    1、收入与成本

    ⑴ 营业收入构成

                                                                                    单位:元

                            2023 年                          2022 年              同比增

                      金额        占营业收入比重        金额        占营业收入比    减

                                                                          重

 营业收入合计  2,626,039,306.71            100%  3,107,945,160.60          100%      -
                                                                                    15.51%

 分行业

 中药行业        100,962,155.07            3.84%    134,537,018.01        4.33%      -
                                                                                    24.96%

 化药行业      2,517,276,946.11          95.86%  2,966,682,749.41        95.45%      -
                                                                                    15.15%

 其他行业          7,800,205.53            0.30%      6,725,393.18        0.22%  15.98%

 分产品

 心脑血管药物    679,825,705.33          25.89%    715,296,444.61        23.02%  -4.96%

 骨科药物        270,398,757.52          10.30%    265,865,821.21        8.55%  1.70%

 营养类药物    1,084,405,601.17          41.29%  1,274,406,407.10        41.00%      -
                                                                                    14.91%

 抗感染药物      63,406,768.44            2.41%    166,186,930.25        5.35%      -
                                                                                    61.85%

 抗肿瘤药物      177,037,197.40            6.74%    226,533,904.99        7.29%      -
                                                                                    21.85%

 电解质类药物    235,658,126.11            8.97%    195,605,292.06        6.29%  20.48%

 血液系统药物      5,840,867.86            0.22%    103,001,122.53        3.31%      -
                                                                                    94.33%

 抗肝炎药物      25,242,639.57            0.96%    28,280,613.73        0.91%      -
                                                                                    10.74%

 消化系统药物    34,028,684.37            1.30%    36,949,415.08        1.19%  -7.90%

 肾病药物        21,061,234.89            0.80%    49,445,526.94        1.59%      -
                                                                                    57.41%

 其他用药领域    21,333,518.52            0.82%    39,648,288.92        1.28%      -
                                                                                    46.19%

 其他业务          7,800,205.53            0.30%      6,725,393.18        0.22%  15.98%

 分地区

 国内          2,623,675,691.19          99.91%  3,101,838,261.05        99.80%      -
                                                                                    15.42%

 国外              2,363,615.52            0.09%      6,106,899.55        0.20%      -
                                                                                    61.30%

 分销售模式

 产品经销模式  2,319,329,366.56          88.32%  2,809,607,862.33        90.40%      -
                                                                                    17.45%

 其他模式        306,709,940.15          11.68%    298,337,298.27        9.60%  2.81%

    ⑵ 营业成本构成

行业和产品分类

                                                                                    单位:元

                                  2023 年                    2022
[点击查看PDF原文]